What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Enzyme
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Neuropeptide Y receptor, Calcitonin gene-related peptide and Vasoactive intestinal peptide.
His study deals with a combination of Internal medicine and Sensory nerve.
His study in Endocrinology is interdisciplinary in nature, drawing from both Neuropeptide and Peptide YY.
His Neuropeptide Y receptor research incorporates elements of Neocortex, Hypothalamus, Somatostatin, Antidepressant and Corticosterone.
His research integrates issues of Calcitonin, Cerebral arteries and Substance P, Neurokinin A in his study of Calcitonin gene-related peptide.
His research investigates the link between Vasoactive intestinal peptide and topics such as Circulatory system that cross with problems in Coronary arteries and Artery.
His most cited work include:
- VASOACTIVE PEPTIDE RELEASE IN THE EXTRACEREBRAL CIRCULATION OF HUMANS DURING MIGRAINE HEADACHE (1162 citations)
- Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. (675 citations)
- Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. (584 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Neuropeptide Y receptor, Neuropeptide and Calcitonin gene-related peptide.
Internal medicine is closely attributed to Delta sleep-inducing peptide in his work.
His research in Endocrinology intersects with topics in Substance P, Vasoactive intestinal peptide and Cerebrospinal fluid.
His Vasoactive intestinal peptide study incorporates themes from Cerebral arteries and Parotid gland.
The Cerebrospinal fluid study combines topics in areas such as Alzheimer's disease, Dementia and Depression.
His work carried out in the field of Neuropeptide Y receptor brings together such families of science as Hypothalamus and Anesthesia.
He most often published in these fields:
- Internal medicine (64.26%)
- Endocrinology (61.97%)
- Neuropeptide Y receptor (22.30%)
What were the highlights of his more recent work (between 2002-2016)?
- Internal medicine (64.26%)
- Endocrinology (61.97%)
- Vasoactive intestinal peptide (15.74%)
In recent papers he was focusing on the following fields of study:
Rolf Ekman mostly deals with Internal medicine, Endocrinology, Vasoactive intestinal peptide, Neuropeptide Y receptor and Motilin.
His research in Internal medicine tackles topics such as Major depressive disorder which are related to areas like Physical exercise.
Rolf Ekman has researched Endocrinology in several fields, including Gastroenterology and Parotid gland.
His study focuses on the intersection of Vasoactive intestinal peptide and fields such as Calcitonin gene-related peptide with connections in the field of Substance P and Cranial nerves.
He works mostly in the field of Neuropeptide Y receptor, limiting it down to topics relating to Anesthesia and, in certain cases, Adrenergic, Lumbar puncture and Antidepressant.
Within one scientific family, Rolf Ekman focuses on topics pertaining to Postprandial under Motilin, and may sometimes address concerns connected to Parkinson's disease, REM sleep behavior disorder, Ingestion and Pancreatic polypeptide secretion.
Between 2002 and 2016, his most popular works were:
- Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. (140 citations)
- Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. (133 citations)
- Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Endocrinology
- Enzyme
Rolf Ekman mainly focuses on Internal medicine, Endocrinology, Immunology, Neuropeptide and Endogenous opioid.
His research brings together the fields of Depression and Internal medicine.
Rolf Ekman specializes in Endocrinology, namely Major depressive disorder.
His Immunology research is multidisciplinary, relying on both Vascular endothelial growth factor A, Vascular endothelial growth factor and Epidermal growth factor.
His Neuropeptide study integrates concerns from other disciplines, such as Calcitonin, Neuroscience, Primary headache and Vasoactive.
His Neuropeptide Y receptor research integrates issues from Calcitonin gene-related peptide, Pathophysiology, Heart failure and Substance P.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
